Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

2.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

3.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

4.

RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung

5.

Screening tests that are non-invasive show promise in detecting colorectal cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot